Partner

  GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research Advancing structural biology research with the GenNext AutoFox® Protein Footprinting System and Agilent 6560 Ion Mobility Quadrupole Time-of-Flight (IM-QTOF) LC/MS system  Half Moon Bay, CA – September 10, 2024 – Today at CASSSS 2024, GenNext Technologies and Agilent announced [...]

GenNext & SCIEX to Co-Market an Advanced High Order Structure Analysis (HOS) Workflow for Biopharmaceutical Research  Together, the companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics.  Half Moon Bay, CA and Framingham, MA – September 14, 2023 – GenNext Technologies, Inc., provider [...]

GenNext® Technologies Announces Partnership with Emery Pharma on Full-Solution Biopharmaceutical Protein Footprinting Services HALF MOON BAY, Calif. – May 17, 2023 – GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announced today that it is collaborating with Emery Pharma, a full-service CRO offering end-to-end biologic drug development support. Through [...]